These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 30993718)

  • 1. Bacterial l-asparaginases for cancer therapy: Current knowledge and future perspectives.
    Ghasemian A; Al-Marzoqi AH; Al-Abodi HR; Alghanimi YK; Kadhum SA; Shokouhi Mostafavi SK; Fattahi A
    J Cell Physiol; 2019 Nov; 234(11):19271-19279. PubMed ID: 30993718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of L-asparaginase in childhood ALL.
    Müller HJ; Boos J
    Crit Rev Oncol Hematol; 1998 Aug; 28(2):97-113. PubMed ID: 9768345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and characterization of Halomonas elongata L-asparaginase, a promising chemotherapeutic agent.
    Ghasemi A; Asad S; Kabiri M; Dabirmanesh B
    Appl Microbiol Biotechnol; 2017 Oct; 101(19):7227-7238. PubMed ID: 28801829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What makes a good new therapeutic L-asparaginase?
    Beckett A; Gervais D
    World J Microbiol Biotechnol; 2019 Sep; 35(10):152. PubMed ID: 31552479
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Van Trimpont M; Schalk AM; De Visser Y; Nguyen HA; Reunes L; Vandemeulebroecke K; Peeters E; Su Y; Lee H; Lorenzi PL; Chan WK; Mondelaers V; De Moerloose B; Lammens T; Goossens S; Van Vlierberghe P; Lavie A
    Haematologica; 2023 Feb; 108(2):409-419. PubMed ID: 35979719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial L-asparaginase as a promising enzyme for treatment of various cancers.
    Darvishi F; Jahanafrooz Z; Mokhtarzadeh A
    Appl Microbiol Biotechnol; 2022 Sep; 106(17):5335-5347. PubMed ID: 35871694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative immunogenicity and structural analysis of epitopes of different bacterial L-asparaginases.
    Pokrovsky VS; Kazanov MD; Dyakov IN; Pokrovskaya MV; Aleksandrova SS
    BMC Cancer; 2016 Feb; 16():89. PubMed ID: 26867931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias
    Nguyen HA; Su Y; Zhang JY; Antanasijevic A; Caffrey M; Schalk AM; Liu L; Rondelli D; Oh A; Mahmud DL; Bosland MC; Kajdacsy-Balla A; Peirs S; Lammens T; Mondelaers V; De Moerloose B; Goossens S; Schlicht MJ; Kabirov KK; Lyubimov AV; Merrill BJ; Saunthararajah Y; Van Vlierberghe P; Lavie A
    Cancer Res; 2018 Mar; 78(6):1549-1560. PubMed ID: 29343523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations.
    Boos J; Werber G; Ahlke E; Schulze-Westhoff P; Nowak-Göttl U; Würthwein G; Verspohl EJ; Ritter J; Jürgens H
    Eur J Cancer; 1996 Aug; 32A(9):1544-50. PubMed ID: 8911116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutant of Escherichia coli asparaginase II to reduction of the glutaminase activity in treatment of acute lymphocytic leukemia by molecular dynamics simulations and QM-MM studies.
    Ardalan N; Mirzaie S; Sepahi AA; Khavari-Nejad RA
    Med Hypotheses; 2018 Mar; 112():7-17. PubMed ID: 29447943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-aspartylpeptides as substrates of L-asparaginases from Escherichia coli and Erwinia chrysanthemi.
    Kelo E; Noronkoski T; Stoineva IB; Petkov DD; Mononen I
    FEBS Lett; 2002 Sep; 528(1-3):130-2. PubMed ID: 12297292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future.
    Avramis VI; Panosyan EH
    Clin Pharmacokinet; 2005; 44(4):367-93. PubMed ID: 15828851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asparaginase in the treatment of non-ALL hematologic malignancies.
    Emadi A; Zokaee H; Sausville EA
    Cancer Chemother Pharmacol; 2014 May; 73(5):875-83. PubMed ID: 24515335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-asparaginase-mediated Therapy in L-asparagine Auxotrophic Cancers: A Review.
    Sindhu R; Manonmani HK
    Anticancer Agents Med Chem; 2022; 22(13):2393-2410. PubMed ID: 34994334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asparaginase Erwinia chrysanthemi as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to E. coli-derived asparaginase.
    Figueiredo L; Cole PD; Drachtman RA
    Expert Rev Hematol; 2016 Mar; 9(3):227-34. PubMed ID: 26765930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of clinical and subclinical hypersensitivity to asparaginase in acute lymphoblastic leukemia.
    Asselin BL; Fisher V
    Clin J Oncol Nurs; 2014 Dec; 18(6):E107-12. PubMed ID: 25427712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent research progress on microbial L-asparaginases.
    Zuo S; Zhang T; Jiang B; Mu W
    Appl Microbiol Biotechnol; 2015 Feb; 99(3):1069-79. PubMed ID: 25492420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and drug monitoring of L-asparaginase treatment.
    Boos J
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):96-8. PubMed ID: 9088996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico Design of a Chimeric Humanized L-asparaginase.
    Pedroso A; Herrera Belén L; Beltrán JF; Castillo RL; Pessoa A; Pedroso E; Farías JG
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial.
    Duval M; Suciu S; Ferster A; Rialland X; Nelken B; Lutz P; Benoit Y; Robert A; Manel AM; Vilmer E; Otten J; Philippe N
    Blood; 2002 Apr; 99(8):2734-9. PubMed ID: 11929760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.